S&P 500

5.299,66

0,05%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Codiak BioSciences Inc (CDAK)
Codiak BioSciences Inc (CDAK) Notícias

CDAK

Codiak BioSciences (CDAK)

Codiak BioSciences Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CDAK

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
30/03/2023	19:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CDAK	Codiak BioSciences Inc
29/03/2023	07:05	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:CDAK	Codiak BioSciences Inc
29/03/2023	07:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CDAK	Codiak BioSciences Inc
27/03/2023	08:00	GlobeNewswire Inc.	Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process	NASDAQ:CDAK	Codiak BioSciences Inc
03/03/2023	18:03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CDAK	Codiak BioSciences Inc
14/02/2023	14:19	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CDAK	Codiak BioSciences Inc
28/11/2022	15:00	GlobeNewswire Inc.	Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference	NASDAQ:CDAK	Codiak BioSciences Inc
10/11/2022	11:00	GlobeNewswire Inc.	Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting	NASDAQ:CDAK	Codiak BioSciences Inc
03/11/2022	17:01	GlobeNewswire Inc.	Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress	NASDAQ:CDAK	Codiak BioSciences Inc
12/10/2022	09:00	GlobeNewswire Inc.	Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses	NASDAQ:CDAK	Codiak BioSciences Inc
05/10/2022	09:00	GlobeNewswire Inc.	Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages	NASDAQ:CDAK	Codiak BioSciences Inc
20/09/2022	17:58	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:CDAK	Codiak BioSciences Inc
14/09/2022	07:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CDAK	Codiak BioSciences Inc
13/09/2022	06:34	TipRanks	Codiak BioSciences (NASDAQ: CDAK) Drops Following Planned Public Offering	NASDAQ:CDAK	Codiak BioSciences Inc
12/09/2022	22:05	GlobeNewswire Inc.	Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants	NASDAQ:CDAK	Codiak BioSciences Inc
12/09/2022	17:01	GlobeNewswire Inc.	Codiak Announces Proposed Public Offering of Common Stock and Warrants	NASDAQ:CDAK	Codiak BioSciences Inc
30/08/2022	10:10	GlobeNewswire Inc.	Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring	NASDAQ:CDAK	Codiak BioSciences Inc
04/08/2022	17:17	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CDAK	Codiak BioSciences Inc
04/08/2022	17:01	GlobeNewswire Inc.	Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational Progress	NASDAQ:CDAK	Codiak BioSciences Inc
03/08/2022	17:15	GlobeNewswire Inc.	Codiak BioSciences to Participate in Upcoming BTIG and Wedbush PacGrow Investor Conferences	NASDAQ:CDAK	Codiak BioSciences Inc
11/07/2022	10:44	GlobeNewswire Inc.	Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022	NASDAQ:CDAK	Codiak BioSciences Inc
05/07/2022	09:33	TipRanks	Goldman Sachs Thinks Codiak BioSciences’ Stock is Going to Recover	NASDAQ:CDAK	Codiak BioSciences Inc
05/07/2022	07:30	GlobeNewswire Inc.	CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccine	NASDAQ:CDAK	Codiak BioSciences Inc
02/07/2022	10:15	TipRanks	Codiak BioSciences (CDAK) Gets a Buy Rating from William Blair	NASDAQ:CDAK	Codiak BioSciences Inc
30/06/2022	07:30	GlobeNewswire Inc.	Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING™ and exoIL-12™	NASDAQ:CDAK	Codiak BioSciences Inc
29/06/2022	09:00	GlobeNewswire Inc.	Codiak Initiates Patient Dosing in Phase 1 Clinical Trial of exoASO™-STAT6 in Patients with Advanced Hepatocellular Carcinoma, Liver Metastases from Primary Gastric Cancer and Colorectal Cancer	NASDAQ:CDAK	Codiak BioSciences Inc
17/05/2022	08:00	GlobeNewswire Inc.	Codiak Presents New Preclinical Data at ASGCT 2022 on Exosome-Based Strategy to Enhance AAV Gene Therapy	NASDAQ:CDAK	Codiak BioSciences Inc
05/05/2022	17:01	GlobeNewswire Inc.	Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational Progress	NASDAQ:CDAK	Codiak BioSciences Inc
04/05/2022	17:27	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CDAK	Codiak BioSciences Inc
02/05/2022	10:00	GlobeNewswire Inc.	Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer	NASDAQ:CDAK	Codiak BioSciences Inc